demonstrated that TP53 inhibits erastin-induced ferroptotic CRC cell death by formation of a P53–DPP4 complex in the nucleus, blocking DPP4 activity, and disassembly of this complex restores the erastin-induced ferroptosis sensitivity30,.31 The gene discussed is TP53; the disease is colorectal carcinoma.